Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Stefanie Lindemann
Observed name:
STEFANIE LINDEMANN
Institution:
Bayer (Germany)
Observed institution:
Bayer (Germany)
OpenAlex ID:
A5114020208
Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism
2008
·
Christopher C Rowe
, Uwe Ackerman
, et al.
·
The Lancet Neurology
·
733
Radiation Dosimetry of β-Amyloid Tracers 11 C-PiB and 18 F-BAY94-9172
2009
·
Graeme J. O'Keefe
, Timothy H. Saunder
, et al.
·
Journal of Nuclear Medicine
·
87
PDF
CKD Prevalence Among Patients With and Without Type 2 Diabetes: Regional Differences in the United States
2021
·
Xue (Snow) Feng
, Ryan Farej
, et al.
·
Kidney Medicine
·
37
Clinical characteristics and disease outcomes in non-diabetic chronic kidney disease: retrospective analysis of a US healthcare claims database
2022
·
Christoph Wanner
, Johannes Schuchhardt
, et al.
·
Journal of Nephrology
·
13
PDF
Assessment of QTc‐prolonging potential of BX471 in healthy volunteers. A ‘thorough QTc study’ following ICH E14 using various QT correction methods
2009
·
Marc Vandemeulebroecke
, Jürgen Lembcke
, et al.
·
British Journal of Clinical Pharmacology
·
12
PDF
First results from human studies of a novel F-18 PET ligand for brain β−amyloid imaging
2007
·
Christopher C. Rowe
, Steven Ng
, et al.
·
Journal of Nuclear Medicine
·
5
O1–04–02: Initial results from human studies of a novel F‐18 PET ligand for brain beta‐amyloid imaging
2007
·
Christopher C. Rowe
, Steven Ng
, et al.
·
Alzheimer s & Dementia
·
1
Mo526real-world Evidence on Clinical Outcomes in Non-diabetic Ckd
2021
·
Christoph Wanner
, Johannes Schuchhardt
, et al.
·
Nephrology Dialysis Transplantation
Mo511baseline Characteristics of a Non-diabetic Ckd Cohort in a Us Claims Database
2021
·
Christoph Wanner
, Johannes Schuchhardt
, et al.
·
Nephrology Dialysis Transplantation
PDF
1479-P: Regional Variations in Chronic Kidney Disease Prevalence among Patients with or without Type 2 Diabetes (RADAR) in the U.S.
2020
·
XUE FENG
, RYAN FAREJ
, et al.
·
Diabetes
IC‐P3‐208: In vivo characterization of 18F‐BAY94–9172: A novel β‐amyloid PET ligand for the diagnosis of Alzheimer's disease
2008
·
Christopher C. Rowe
, Uwe Ackermann
, et al.
·
Alzheimer s & Dementia
PDF
P1‐285: First results toward in vivo quantification of cerebral β‐amyloid plaque load in Alzheimer's disease by means of BAY 94–9172‐PET
2008
·
Osama Sabri
, Henryk Barthel
, et al.
·
Alzheimer s & Dementia
O1‐02–07: In vivo characterization of 18F‐BAY94–9172: A novel β‐amyloid PET ligand for the diagnosis of Alzheimer's disease
2008
·
Christopher C. Rowe
, Uwe Ackermann
, et al.
·
Alzheimer s & Dementia
Radiation dosimetry of the amyloid imaging agent 18F-BAY94-9172 in humans
2008
·
Timothy Saunder
, Gareth Jones
, et al.
·
Journal of Nuclear Medicine
Show more works
View as search
Works count:
14
Citation count:
889
H-index:
5
I10-index:
5
Year
Topic
Type